Higher Radiotherapy Doses But Fewer Treatment Sessions May Be Possible, Early Trial Data Suggest

Higher Radiotherapy Doses But Fewer Treatment Sessions May Be Possible, Early Trial Data Suggest
Prostate cancer patients may benefit from a new form of radiation therapy that delivers larger doses per session but in a much shorter treatment course, and when used in combination with a hydrogel spacer that helps to protect the rectum, early results from the ongoing SPORT trial suggest. Stereotactic Ablative Body Radiotherapy or SABR uses small, thin beams of radiation that are directed into the tumor from different angles. The treatment targets the tumor, which receives a high dose of radiation, while avoiding healthy tissues nearby. SABR allows for dose escalation, which conventional radiotherapy cannot, and patients can finish a full course of radiotherapy in five hospital visits instead of the standard 37. The SPORT trial (
Subscribe or to access all post and page content.